Targeting MAPK4 may offer a new therapeutic opportunity for TNBC
MAPK4 seems to be involved in promoting triple-negative breast cancer growth and its resistance to certain therapies.
Read MoreMAPK4 seems to be involved in promoting triple-negative breast cancer growth and its resistance to certain therapies.
Read MoreResearchers at Baylor College of Medicine have validated a new type of genetic mutation that causes Xia-Gibbs Syndrome, a rare genetic disorder.
Read MoreThe researchers found that each type of feeding is wired by its own independent circuit that does not influence the other type.
Read MoreInhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read MoreResearchers developed a novel PROTAC with enhanced intracellular accumulation and improved ability to neutralize target proteins inside cells.
Read MoreCAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read MoreKeeping blood sugar in balance can be a challenge, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood
Read MoreResearchers have found that the bone microenvironment can promote the growth and progression of breast cancer micrometastasis, a small group of cancer cells that separates
Read MoreThe prognosis of a cancer patient relies significantly on the ability of the surgeon to remove all the tumor, including a cancer-free boundary, leaving what
Read MoreIt used to be that identifying genes involved in a particular disease was like finding a needle in a haystack. Nowadays, scientists still have to
Read More